We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Ink
Careers
Categories: Life Sciences, Pharma, Biotech, Deals & Cases
ABBA Therapeutics AG, a Swiss biotechnology company developing innovative immuno-oncology therapies, and Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) have entered into a worldwide license agreement. Under the license, ABBA Therapeutics AG will be able to use the OmniRat, OmniMouse and OmniFlic platforms to generate fully human mono- and bispecific antibodies. VISCHER advised ABBA Therapeutics AG in the negotiations. The VISCHER team includes partner Christian Wyss and Luzius Zumstein.
Attorney at Law
ImmunOs Therapeutics AG, in Schlieren, a biopharmaceutical company developing first-in-class...
Developing a product or service and scaling a startup's business model need big amounts of cash....
HAYA Therapeutics SA, a Swiss biotechnology company pioneering precision RNA-guided regulatory...
